RIBOMAB holds 0 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 1 filings. The WikiTrademarks Expansion Score is 5/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed June 15, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is RIBOMAB filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 79218814 | RIBOMAB | Aug 22, 2017 | Pending | 005 Pharmaceuticals 040 Material Treatment 042 Science & Technology 044 Medical & Beauty Services | BioNTech SE |
Weekly visibility reports showing how ChatGPT mentions RIBOMAB, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: RIBOMAB trademark portfolio
What trademarks does RIBOMAB hold?
RIBOMAB holds 0 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals), Class 40 (Material Treatment), Class 42 (Science & Technology). The most recent filings are registered to BioNTech SE.
How many trademarks does RIBOMAB have at the USPTO?
WikiTrademarks tracks 0 USPTO trademark filings attributed to RIBOMAB. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does RIBOMAB file most often?
RIBOMAB's most active class is NICE Class 5 (Pharmaceuticals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the RIBOMAB trademark?
The most recent filings under the RIBOMAB mark are registered to BioNTech SE. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is RIBOMAB expanding into new categories?
The current WikiTrademarks Expansion Score for RIBOMAB is 5 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new RIBOMAB trademark filings?
Click the Watch Brand button at the top of this page to add RIBOMAB to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare RIBOMAB to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about RIBOMAB and help the next person researching it.